Traditionally, neonatal-perinatal medicine has been concerned with two areas of research: basic and translational. A third area, perinatal epidemiology/health outcomes research addresses those factors that impede and promote the clinical actualization of the advances developed by basic and translational research. Unfortunately, research and training in perinatal epidemiology and outcomes analysis have not kept pace with our need to understand the interplay between risk, intervention, structure and outcome. This knowledge is essential to the development of the clinical/ organizational and training strategies that will enable perinatal medicine to fully realize the promise of basic and translational research. Journal of Perinatology (2006) 26, S34-S37. doi:10.1038/sj.jp.7211444
Neonatal-perinatal medicine has traditionally been concerned with two broad categories of research: basic and translational. Basic research adds to our understanding of the fundamental principles of developmental biology. Translational research utilizes this fundamental knowledge to develop interventions to decrease perinatal mortality and morbidity. The use of antenatal steroids for women in premature labor in order to accelerate intrauterine maturation and decrease the severity of respiratory distress syndrome and the incidence of intraventricular hemorrhage is an important example of clinical advancement that resulted from these two traditional pillars of perinatal research. 1 Although it is estimated that one should be able to treat 85% of women who are in labor at 24-38 weeks of gestation, across hospitals there is significant variability in the extent to which this therapy is utilized. 2 More accurately stated, antenatal steroids is an important example of the advancement that is possible if this intervention is conducted in all qualifying situations. Unfortunately, medical interventions are not always conducted in all qualifying situations, resulting in underuse. And when conducted, medical interventions may not always be administered in the correct manner, resulting in overuse and misuse. 3 To understand the factors that influence the ways in which medical interventions are utilized requires a third area of research. This third essential area, operational research, addresses those factors that impede and promote the clinical actualization of the advances developed by basic and translational research. As the goal of operational research is to optimize health outcomes, it is often referred to as health outcomes research.
Health outcomes research seeks to understand the origins of outcome by (1) characterizing the social and genetic factors as well as their resultant comorbidities that create the specific risk-needs that call for medical intervention, (2) determining the critical factors that shape the ways in which the practitioner perceives need, and then selects and conducts medical interventions to address it, and (3) by comparing the observed result to an 'ideal' outcome that has been demonstrated to be possible in similar patients. Broadly considered, these three steps involve the analytic approaches developed by epidemiology and quality of care research. Epidemiologic methodologies are needed to establish outcome expectations. 4 Quality care research is required to identify the factors responsible for failing to achieve expected outcomes and armed with this knowledge to develop strategies for outcome improvement. 5 From an interventions perspective, these strategies primarily address issues of underuse, overuse and misuse. 3 The goal of health outcomes research is to decrease morbidity and mortality by seeking to optimize diagnosis (assessment of risk/ need), prescription (selection of therapeutic strategy) and treatment (strategy implementation). While basic and translational research strives to advance medical care, outcomes research strives to assure that this care is optimally utilized and applied. Figure 1 shows a schematic of the traditional major factors (social-environmental, genomic, fetal condition, etc.) that influence neonatal health and serves to illustrate the many points at which the quality of perinatal care impacts on neonatal outcome.
It is of some importance to the discussion of research and training directions in perinatal medicine that the notion of the differential application of medical care is relatively new. Until the 1970s, it was generally accepted that the quality of medical care was beyond question, medical mishaps were uncommon and newly discovered effective therapies were rapidly and effectively incorporated into practice. The publication of a series of studies on the variability of illness, hospitalizations and outcomes in the 1970s dispelled this by demonstrating that after controlling for differences in severity of illness and comorbidity, there were significant differences in the quality of outcomes achieved across hospitals. 6, 7 This observation, that some hospitals had consistently better outcomes, brought the issue of quality of care to light. Over the last three decades, this light has intensified to a degree where the early 2000s have been called a quality care revolution. 8 However, while there is a great deal of multisectorial enthusiasm (and pressure 9 ) for perinatal services to achieve optimal outcomes, both research and training in perinatal epidemiology and outcomes have not kept pace with our need to understand the interplay between risk, intervention, structure and outcome. Knowledge that is essential to the development of the clinical/ organizational and training strategies that will enable perinatal medicine to fully realize the promise of basic and translational research. To achieve this will require a significant creative effort. Yet, only a handful of perinatal-neonatal training programs have senior investigators with interest and experience in perinatal epidemiology/outcomes research. Furthermore, the availability of the large multi-institutional databases that are essential to this line of inquiry is very limited. And finally, many fundamental areas of inquiry have received little attention. I would like to illustrate this last point by describing several gaps, in knowledge that could powerfully impact perinatal outcomes.
To illustrate the first of these gaps let us briefly consider the role of structure. Structural factors such as staffing, staff competency, the availability of support services and organizational structure are important shapers of perinatal outcomes. Yet, there has been little investigation in this area. The potential importance of structural considerations is vividly illustrated by recent investigations of the role of time of birth on the risk of neonatal death. In a study of Swedish births, Stephansson et al. 10 found that after controlling for differences in case mix, the first week mortality of singletons born at night was increased 28%. Most importantly, these excess deaths accounted for almost 12% of all early neonatal deaths. These findings are not isolated to Europe, but have also been confirmed in California. Gould et al.
11 demonstrated that after controlling for differences in case mix, neonatal mortality increased 12% during the early and 16% during the late night. The excess mortality accounted for 9.6% of all neonatal deaths in California. 11 What are the factors responsible for these excess deaths? The observation that similar elevations in the early and late night suggests that structural factors such as staffing, support services and organizational structure rather than fatigue are the source of the increased mortality. However, what are the responsible structural factors, and once identified, how do we overcome them. Research aimed at identifying and ameliorating the factors that generate this large burden of mortality should be a high priority for perinatal research. Unfortunately, there are few young perinatal investigators with the training and experience to conduct this essential research. Research that could reduce neonatal mortality by almost 10%.
A second gap is the identification of the relationship between innovations in medical care and the gains made in reducing a population's morbidity and mortality. We have a great deal of information from controlled clinical trials on the extent to which specific therapies impact the health of trial subjects. 12 We also have the ability to estimate the number needed to treat with a new therapy to achieve a specific level of risk/benefit. 13 National trends in neonatal mortality give us a composite picture of the overall impact of advances in perinatal care. However, there is very little research on the population impact of these advances, whether they are differentially applied in certain subpopulations, and the role of this differential application in the generation of racial and socioeconomic disparities in health outcomes. Work suggesting that surfactant use lagged behind in African Americans is an important example of this type of research.
14 Could this differential application of surfactant contribute to the recently reported national decrease in the very low birth weight (VLBW) African American survival advantage? Figure 2 , taken from the masters thesis of Dr Methodius Tuli, illustrates this survival trend. In 1989, the mortality of 750-1000 g white infants born in California was 93% higher than that of 750-1000 g black infants. 15 Over the period 1989-2000, mortality has decreased more rapidly in white infants, so that by 2000 white mortality was only 17% higher. What accounts for this differential improvement? Are African-American infants less biologically responsive to the innovations in care, or has there been differential access and/or application. And what exactly were the relative contributions of the advancements. What were the specific impacts of surfactant, antenatal steroids, Figure 1 Schematic of the traditional major factors (socialenvironmental, genomic, fetal condition, etc.) that influence neonatal health and the many points at which the quality of perinatal care impacts neonatal outcome.
resuscitation and other advances in NICU and obstetric care to the decrease in neonatal mortality? Health outcomes research is essential to understand the impact of medical advances, their relative risks and benefits, and their differential application. This knowledge is fundamental if we are to optimize their utilization.
A third gap is in the granularity of the outcomes that we utilize to assess quality of care. In some areas, such as the assessment of neurodevelopmental outcomes, granularity has been substantially increased with respect to both the subtlety and range of dysfunction that is being tracked and the time frame of observation. Over the last three decades, evaluations have evolved from the enumeration of a limited set of catastrophic intellectual and sensory-motor deficits observed in the first few years of life to a broader spectrum that attempts to characterize the functional integrity in both life and educational settings of neonatal intensive-care graduates who are now in their teens. 16, 17 And yet to characterize differences in quality across perinatal units, we still most often rely upon neonatal mortality at a time when mortality is becoming increasingly less common and as a consequence less statistically powerful. While, as illustrated in Figure 3 , mortality may still be useful in examining some situations such as the difference in mortality of VLBW infants born in a primary care vs a regional NICU hospital, 18 the absence of mortality difference across institutions does not rule out that there may be important differences in the quality of care. Mortality may be equivalent in situations where there are dramatic differences in morbidity. In the course of designing a statewide risk adjustment strategy to identify the overuse of cesarean delivery rates, investigators at the California Perinatal Quality Care Collaborative (PQCC) were concerned that, although hospitals were given credit for having low-case mixadjusted cesarean (CS) delivery rates, the safety of performing a lower than expected number of cesarean deliveries had not been established. Was it possible that some vaginally delivered infants at low CS hospitals may have benefited from cesarean delivery? To explore this, we evaluated infants born at term to low-risk mothers at hospitals with average and lower than average rates of cesarean delivery. Using neonatal mortality (an indicator that is ubiquitous in evaluating differences in the quality of care across hospitals, races, socioeconomic class and levels of perinatal care), we found no significant differences (P ¼ 0.10) in the mortality of infants born at average (0.19/1000) and lower than average (0.13/1000) average CS hospitals. In fact, some might believe that there could be a trend towards lower mortality in the low CS hospitals. When we increased the granularity of our analysis, we found that morbidity such as asphyxia and meconium aspiration, and the use of interventions such as mechanical ventilation and pressors (based upon ICD-9 codes at discharge) were increased in some instances by 74%. 19 Developing efficient methods for assigning levels of morbidity represents an important health outcomes challenge, especially because diagnoses and outcomes that may signal a problem in term babies such as the need to have pressors or mechanical ventilation are common in very tiny infants. A second challenge is how to summarize the results from several quality indicators given the observation that nurseries that are outliers for one outcome may often provide benchmark levels for another outcome. Only further research will tell if these parings are unrelated or if in some cases success in one area is being achieved at the expense of another.
Training considerations
In the above discussion, I have tried to point out the importance of Epidemiology/Health Outcomes Research. Epidemiologic research helps to identify those at greatest risk and to understand the basis for their increased risk. It is also important in estimating an expected outcome, given a specific set of circumstances, as this expectation serves as the cornerstone of quality assessment. Health outcomes research addresses those factors that limit the potential application of advances made by basic and translational research, and develops interventions to overcome these limitations. Before outlining the training requirements, it is important to note that the laboratory required to investigate these issues is quite different from those utilized by basic and translational research. Basic research can be pursued with the resources available within a single laboratory. Translational research can sometimes be conducted within the clinical service of a single institution, but often requires several nurseries in order to achieve sample sizes required for statistical power. In sharp contrast, health outcomes research requires a large network of perinatal units, in order to identify and investigate variations in outcomes and the factors which generate these differences. An essential requirement of a training program in this area is that it has access to a large multi-institutional database.
The goal of perinatal training in Perinatal Epidemiology/Health outcomes research is to develop a clinical researcher who has (1) solid competence in neonatal/perinatal medicine, (2) the methodological expertise and experience to conduct this type of research and (3) the ability to design and conduct quality improvement interventions. The training program that we have developed at Stanford has been designed to meet these objectives. The program provides the research component of Stanford's neonatal fellowship, but can be a stand-alone experience for neonatologists who have successfully completed their fellowship. In addition to seminars and mentored activities within the program, during the course of their fellowship trainees are expected to obtain a masters degree in epidemiology or health services research. The masters thesis research is jointly supervised by a mentor from the academic program and a mentor from the fellowship program. The thesis research may serve as the major fellowship research requirement. The program also provides training in utilizing clinical and survey-based secondary data and in database design. An important aspect of the training program is to provide experience in quality improvement interventions. During the fellowship, the fellow gets this experience by participating in concurrent quality indicators, cycle design, toolkit and educational program development, and outcomes tracking as a member of Perinatal Quality Improvement Panel of CPQCC. Research is currently in progress utilizing the CPQCC NICU database of 110 NICUs, California's linked birth/death/hospitals discharge data set that includes over 300 delivery hospitals and the US National Linked Birth/Death Database. While the specific components and emphasis may vary across training programs, I feel that the Stanford program is representative of the type of training that is needed to advance research in the area of Perinatal epidemiology/ Health outcomes.
